Founding investor Lundbeckfonden Emerge returned to co-lead a series A round for the gene editing drug developer with Life Science Partners.

Denmark-based biotechnology company Snipr Biome secured $50m yesterday in a series A round co-led by life sciences foundation Lundbeck Foundation’s early-stage investment unit, Lundbeckfonden Emerge. Healthcare investment firm Life Science Partners (LSP) co-led the round, which also featured North-East Family Office and venture capital firm Wellington Partners. Snipr is developing treatments intended to precisely target…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.